These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17292608)

  • 1. Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N-aryl bicyclic hydantoin-based selective androgen receptor modulators.
    Hamann LG; Manfredi MC; Sun C; Krystek SR; Huang Y; Bi Y; Augeri DJ; Wang T; Zou Y; Betebenner DA; Fura A; Seethala R; Golla R; Kuhns JE; Lupisella JA; Darienzo CJ; Custer LL; Price JL; Johnson JM; Biller SA; Zahler R; Ostrowski J
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1860-4. PubMed ID: 17292608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and SAR of novel hydantoin derivatives as selective androgen receptor modulators.
    Zhang X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5763-6. PubMed ID: 16959487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of novel hydantoin-containing melanin-concentrating hormone receptor antagonists.
    Balavoine F; Malabre P; Alleaume T; Rey A; Cherfils V; Jeanneton O; Seigneurin-Venin S; Revah F
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3754-9. PubMed ID: 17448659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synthesis and evaluation of [2.2.1]-bicycloazahydantoins as androgen receptor antagonists.
    Balog A; Salvati ME; Shan W; Mathur A; Leith LW; Wei DD; Attar RM; Geng J; Rizzo CA; Wang C; Krystek SR; Tokarski JS; Hunt JT; Gottardis M; Weinmann R
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6107-11. PubMed ID: 15546739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent androgen antagonists based on carborane as a hydrophobic core structure.
    Fujii S; Goto T; Ohta K; Hashimoto Y; Suzuki T; Ohta S; Endo Y
    J Med Chem; 2005 Jul; 48(14):4654-62. PubMed ID: 16000001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel non-steroidal/non-anilide type androgen antagonists: discovery of 4-substituted pyrrole-2-carboxamides as a new scaffold for androgen receptor ligands.
    Wakabayashi K; Miyachi H; Hashimoto Y; Tanatani A
    Bioorg Med Chem; 2005 Apr; 13(8):2837-46. PubMed ID: 15781394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of novel androgen receptor antagonists with sterically bulky icosahedral carboranes.
    Goto T; Ohta K; Suzuki T; Ohta S; Endo Y
    Bioorg Med Chem; 2005 Dec; 13(23):6414-24. PubMed ID: 16099660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel selective androgen receptor modulators: SAR studies on 6-bisalkylamino-2-quinolinones.
    van Oeveren A; Motamedi M; Martinborough E; Zhao S; Shen Y; West S; Chang W; Kallel A; Marschke KB; López FJ; Negro-Vilar A; Zhi L
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1527-31. PubMed ID: 17267219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a 4-(hydroxymethyl)diarylhydantoin as a selective androgen receptor modulator.
    Nique F; Hebbe S; Triballeau N; Peixoto C; Lefrançois JM; Jary H; Alvey L; Manioc M; Housseman C; Klaassen H; Van Beeck K; Guédin D; Namour F; Minet D; Van der Aar E; Feyen J; Fletcher S; Blanqué R; Robin-Jagerschmidt C; Deprez P
    J Med Chem; 2012 Oct; 55(19):8236-47. PubMed ID: 22957947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of androgen receptor antagonists with bulky side chains for overcoming antiandrogen resistance.
    Zhou J; Geng G; Shi Q; Sauriol F; Wu JH
    J Med Chem; 2009 Sep; 52(17):5546-50. PubMed ID: 19725582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationships of the first ferrocenyl-aryl-hydantoin derivatives of the nonsteroidal antiandrogen nilutamide.
    Payen O; Top S; Vessières A; Brulé E; Plamont MA; McGlinchey MJ; Müller-Bunz H; Jaouen G
    J Med Chem; 2008 Mar; 51(6):1791-9. PubMed ID: 18303829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of an androgen receptor modulator pharmacophore based on 2-quinolinones.
    van Oeveren A; Pio BA; Tegley CM; Higuchi RI; Wu M; Jones TK; Marschke KB; Negro-Vilar A; Zhi L
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1523-6. PubMed ID: 17257838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.
    Budzik B; Wang Y; Shi D; Wang F; Xie H; Wan Z; Zhu C; Foley JJ; Nuthulaganti P; Kallal LA; Sarau HM; Morrow DM; Moore ML; Rivero RA; Palovich M; Salmon M; Belmonte KE; Laine DI; Jin J
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1686-90. PubMed ID: 19243945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the development of selective androgen receptor modulators.
    Zhang X; Lanter JC; Sui Z
    Expert Opin Ther Pat; 2009 Sep; 19(9):1239-58. PubMed ID: 19505196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of substituted 2,4,4-triarylimidazoline derivatives as potent and selective neuropeptide Y Y5 receptor antagonists.
    Sato N; Jitsuoka M; Ishikawa S; Nagai K; Tsuge H; Ando M; Okamoto O; Iwaasa H; Gomori A; Ishihara A; Kanatani A; Fukami T
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1670-4. PubMed ID: 19233647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships in non-ligand binding pocket (non-LBP) diarylhydrazide antiandrogens.
    Caboni L; Egan B; Kelly B; Blanco F; Fayne D; Meegan MJ; Lloyd DG
    J Chem Inf Model; 2013 Aug; 53(8):2116-30. PubMed ID: 23834240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR5 receptor antagonists: discovery and SAR of novel 4-hydroxypiperidine derivatives.
    Lu SF; Chen B; Davey D; Dunning L; Jaroch S; May K; Onuffer J; Phillips G; Subramanyam B; Tseng JL; Wei RG; Wei M; Ye B
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1883-7. PubMed ID: 17314043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discovery of a potent orally efficacious indole androgen receptor antagonist through in vivo screening.
    Lanter JC; Fiordeliso JJ; Jiang W; Allan GF; Lai MT; Linton O; Hahn do W; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2007 Jan; 17(1):123-6. PubMed ID: 17071085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and SAR of potent and selective androgen receptor antagonists: 5,6-Dichloro-benzimidazole derivatives.
    Ng RA; Guan J; Alford VC; Lanter JC; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2007 Feb; 17(3):784-8. PubMed ID: 17095226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel aminothiadiazole amides as selective EP(3) receptor antagonists.
    Hilfiker MA; Wang N; Hou X; Du Z; Pullen MA; Nord M; Nagilla R; Fries HE; Wu CW; Sulpizio AC; Jaworski JP; Morrow D; Edwards RM; Jin J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4292-5. PubMed ID: 19487124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.